background
sever
fever
thrombocytopenia
syndrom
sft
emerg
diseas
first
report
china
caus
sft
viru
sftsv
member
phleboviru
genu
bunyavirida
famili
sftsv
classifi
pathogen
need
develop
safe
afford
serodiagnost
method
proper
clinic
manag
infect
patient
method
full
length
nucleocapsid
n
gene
sftsv
yamaguchi
strain
amplifi
rtpcr
clone
express
vector
recombin
r
sftsvn
protein
express
use
escherichia
coli
e
coli
express
system
purifi
nativ
condit
rsftsvn
protein
base
indirect
igg
igm
enzym
link
immunosorb
assay
elisa
system
establish
detect
specif
human
igg
igm
antibodi
respect
one
hundr
fifteen
serum
sampl
clinic
suspectedsft
patient
use
evalu
newli
establish
system
result
compar
total
antibodi
detect
sandwich
elisa
system
result
nativ
form
recombin
r
sftsvn
protein
express
purifi
applic
rsftsvn
protein
base
indirect
igg
elisa
serum
sampl
show
result
perfectli
match
total
antibodi
sandwich
elisa
sensit
specif
rsftsvn
protein
base
indirect
igm
elisa
miss
posit
sampl
detect
total
antibodi
sandwich
elisa
sensit
specif
rsftsvnigm
captur
elisa
respect
rsftsvn
protein
highli
immunoreact
good
target
use
assay
antigen
laboratori
diagnosi
prepar
simpler
comparison
use
total
antibodi
sandwich
system
rsftsvn
proteinbas
igg
igm
elisa
system
advantag
distinguish
two
type
antibodi
requir
small
volum
serum
sampl
safe
use
diagnosi
sft
viru
infect
especi
fit
largescal
epidemiolog
investig
sever
fever
thrombocytopenia
syndrom
viru
sftsv
also
name
fever
thrombocytopenia
leukopenia
syndrom
viru
ftlsv
huaiyangshan
viru
emerg
viru
first
report
sourc
serum
sampl
viru
identifi
patient
infect
china
sever
fever
thrombocytopenia
syndrom
sft
diseas
caus
viru
major
clinic
present
includ
fever
thrombocytopenia
leukocytopenia
gastrointestin
symptom
neurolog
symptom
bleed
tendenc
well
less
specif
clinic
manifest
diseas
casefat
rate
rang
differ
area
endem
humantohuman
transmiss
sftsv
report
occur
close
contact
blood
andor
bodi
secret
infect
patient
first
identif
sft
sft
case
report
provinc
china
recent
exist
diseas
also
confirm
japan
south
korea
japan
casefat
rate
appar
higher
china
averag
case
fatal
data
high
fatal
rate
due
sftsv
indic
sftsv
threat
human
health
anoth
tickborn
phleboviru
heartland
viru
detect
missouri
phylogenet
associ
sftsv
caus
sever
febril
ill
thrombocytopenia
leukopenia
total
blood
cell
count
elev
level
liver
enzym
diagnosi
sft
laboratori
confirm
essenti
clinic
manifest
sft
nonspecif
viru
isol
blood
virem
patient
direct
evid
sftsv
infect
howev
timeconsum
need
high
secur
biocontain
facil
detect
sftsv
genom
could
achiev
differ
nucleic
acid
detect
techniqu
revers
transcriptionpcr
rtpcr
realtim
rtpcr
revers
transcriptionloopmedi
isotherm
amplif
assay
rtlamp
revers
transcriptioncrossprim
amplif
coupl
rtcpa
vertic
flow
vf
visual
although
techniqu
high
sensit
specif
earli
diagnosi
durat
viraemia
sftsv
infect
short
gener
day
diseas
onset
henc
nucleic
acid
detect
techniqu
applic
acut
phase
diseas
within
week
onset
final
confirm
infect
mani
case
may
reli
detect
specif
antibodi
sftsv
sftsv
member
phleboviru
genu
bunyavirida
famili
like
bunyavirus
l
segment
encod
rnadepend
rna
polymeras
segment
open
read
frame
orf
code
gngc
precursor
order
gngc
wherea
segment
use
ambisens
code
express
two
protein
one
nucleocapsid
n
protein
encod
half
viral
complementari
sens
rna
nonstructur
ns
protein
encod
viral
sens
rna
nucleocapsid
n
protein
one
immunodomin
viral
protein
among
member
bunyavirida
famili
recombin
n
protein
rift
valley
fever
rvf
viru
anoth
member
phleboviru
genu
report
use
detect
system
laboratori
diagnosi
rfv
infect
human
anim
sftsv
jiao
et
al
develop
recombin
n
protein
base
sandwich
enzym
link
immunosorb
assay
elisa
detect
total
antibodi
viru
human
anim
present
report
recombin
sftsvn
rsftsvn
protein
express
use
escherichia
coli
e
coli
express
system
purifi
rsftsvn
protein
base
igg
elisa
igm
elisa
system
establish
serum
sampl
clinicallysuspect
sft
patient
use
evalu
newli
establish
system
result
compar
obtain
use
total
antibodi
detect
sandwich
elisa
system
sftsv
nucleocapsid
gene
encod
amino
acid
residu
full
length
nucleocapsid
protein
success
amplifi
rtpcr
clone
express
vector
frame
downstream
sixhistidin
tag
fig
sequenc
read
frame
n
gene
confirm
dna
sequenc
recombin
plasmid
recombin
protein
success
express
e
coli
express
protein
solubl
lane
rsftsvn
protein
purifi
supernat
nativ
condit
analysi
purifi
recombin
protein
sdspage
coomassi
blue
stain
reveal
singl
protein
band
predict
amino
acid
sequenc
nucleocapsid
protein
fig
lane
ident
rsftsvn
protein
confirm
western
blot
assay
mous
monoclon
antibodi
histidin
use
sft
patient
serum
sampl
fig
determin
appropri
dilut
serum
sampl
indirect
igg
igm
elisa
use
rsftsvn
protein
mention
sampl
healthi
volunt
sft
confirm
patient
dilut
twofold
applic
igg
elisa
serum
sampl
healthi
volunt
gave
optic
densiti
od
valu
lower
dilut
sampl
higher
dilut
od
valu
sampl
od
valu
two
serum
sampl
sftsconfirm
patient
chang
much
valu
dilut
reduc
dilut
base
result
dilut
serum
sampl
igg
elisa
set
conveni
igm
elisa
healthi
volunt
sampl
gave
od
valu
dilut
sampl
gave
reduc
valu
dilut
od
valu
two
sampl
sftsconfirm
patient
reduc
dilut
dilut
thu
dilut
igm
elisa
set
set
serum
dilut
igg
igm
healthi
volunt
serum
sampl
gave
od
valu
henc
cutoff
give
neg
result
set
among
serum
sampl
sftssuspect
patient
sampl
posit
rsftsvn
proteinbas
indirect
igg
elisa
neg
od
valu
neg
sampl
rang
posit
sampl
result
perfectli
match
result
obtain
use
total
antibodi
tabl
among
serum
sampl
sftssuspect
patient
sampl
posit
neg
rsftsvn
proteinbas
indirect
igm
elisa
od
valu
neg
sampl
rang
posit
sampl
indirect
igm
elisa
fail
detect
eight
sampl
posit
total
antibodi
sandwich
elisa
kit
compar
kit
sensit
specif
rsftsvnigm
captur
elisa
respect
tabl
present
studi
express
rsftsv
nucleocapsid
protein
e
coli
purifi
recombin
protein
near
homogen
histag
base
affin
chromatographi
nativ
condit
use
assay
antigen
indirect
igg
igm
elisa
nucleocapsid
protein
abund
protein
mani
virus
recombin
nucleocapsid
protein
use
serodiagnosi
mani
virus
like
sar
nipah
virus
phleboviru
famili
rvf
viru
n
protein
good
target
igg
igm
elisa
system
sft
viru
one
report
develop
elisa
system
doubleantigen
sandwich
assay
system
make
use
recombin
n
protein
detect
total
antibodi
system
valid
neutral
test
total
antibodi
elisa
kit
use
present
studi
base
system
contrast
prepar
recombin
n
protein
use
antigen
sandwich
assay
system
recombin
protein
mostli
solubl
purifi
nativ
condit
without
use
deterg
therebi
skip
arduou
work
refold
denatur
protein
express
purif
procedur
describ
studi
provid
simpl
effici
way
obtain
pure
sftsv
n
protein
larg
quantiti
use
rsftsvn
protein
develop
indirect
igg
igm
elisa
human
serum
compar
commerci
total
antibodi
detect
sandwitch
elisa
kit
evalu
serum
sampl
sftsvsuspect
patient
show
concord
rate
igg
igm
elisa
comparison
total
antibodi
detect
sandwitch
elisa
kit
respect
sensit
specif
rsftsvn
protein
base
indirect
igg
elisa
system
regard
total
antibodi
detect
sandwitch
elisa
kit
tabl
sensit
specif
rsftsvn
protein
base
indirect
igm
elisa
system
respect
regard
total
antibodi
detect
sandwitch
elisa
kit
tabl
indirect
igm
elisa
system
fail
catch
eight
sampl
posit
total
antibodi
kit
may
caus
lower
sensit
indirect
igm
elisa
method
igm
antibodi
sftsv
exist
sampl
serum
sampl
collect
sft
suspect
patient
recov
ill
posit
sampl
specif
igg
tabl
well
known
igg
compet
igm
bind
antigen
therebi
reduc
sensit
indirect
igm
elisa
still
indirect
igm
elisa
sensit
accept
level
clinic
diagnosi
especi
use
develop
countri
sensit
diagnosi
method
current
develop
igm
captur
elisa
system
total
antibodi
sandwichelisa
system
develop
jiao
et
al
wide
use
china
simpl
perform
could
use
human
kind
anim
disadvantag
method
distinguish
igg
igm
volum
serum
serum
use
without
dilut
requir
assay
thu
limit
applic
clinic
diagnosi
larg
scale
epidemiolog
studi
sftsvn
protein
base
system
detect
igg
igm
separ
distinguish
previou
recent
infect
respect
serum
dilut
igg
igm
greatli
save
serum
use
quit
benefici
preciou
sampl
larg
scale
epidemiolog
studi
rsftsvn
protein
base
indirect
igg
igm
elisa
system
present
elimin
use
infecti
viru
antigen
product
requir
high
level
microbiolog
secur
facil
henc
safer
method
diagnosi
express
purif
procedur
recombin
sftsvn
protein
simpl
easi
allow
easi
standard
antigen
product
advantag
use
prokaryot
host
produc
recombin
sftsvn
protein
would
consider
due
eas
scaleup
low
cost
involv
grow
bacteria
would
especi
use
case
largescal
epidemiolog
investig
applic
develop
countri
conclus
rsftsvn
protein
highli
immunoreact
human
infect
good
target
laboratori
diagnosi
rsftsvn
proteinbas
igg
igm
elisa
system
safe
specif
sensit
tool
serolog
diagnosi
sft
viru
infect
especi
fit
use
largescal
epidemiolog
investig
two
serum
sampl
sftsconfirm
patient
collect
serum
sampl
healthi
volunt
collect
year
earliest
identifi
sft
patient
reportedwer
use
posit
neg
control
respect
determin
serum
dilut
igg
igm
indirect
elisa
develop
present
studi
evalu
two
assay
serum
sampl
collect
henan
provinc
china
use
studi
sampl
collect
patient
recov
ill
suspect
sft
yamaguchi
strain
sftsv
genbank
access
isol
patient
yamaguchi
prefectur
japan
inocul
confluent
monolay
cell
cell
maintain
eagl
minimum
essenti
medium
supplement
fetal
calf
serum
mm
nonessenti
amino
acid
day
infect
cultur
fluid
icf
harvest
icf
viral
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
accord
manufactur
instruct
extract
rna
elut
elut
buffer
use
templat
rtpcr
rtpcr
perform
use
primer
gener
full
length
n
gene
sftsv
sens
revers
primer
contain
sphi
hind
iii
restrict
site
underlin
respect
pcr
amplifi
dna
fragment
digest
sphi
hind
iii
purifi
qiaex
ii
gel
extract
kit
qiagen
hilden
germani
subsequ
clone
correspond
restrict
site
vector
qiagen
hilden
germani
insert
recombin
plasmid
confirm
frame
dna
sequenc
express
construct
encompass
amino
acid
aa
full
length
sftsv
n
protein
vector
deriv
histag
histidin
hexmer
nterminu
obtain
result
recombin
protein
design
rsftsvn
protein
rsftsvn
protein
express
insert
recombin
plasmid
contain
sftsvn
sequenc
e
coli
strain
blue
cultur
luriabertani
lb
medium
contain
ampicillin
optic
densiti
od
nm
cultur
reach
express
recombin
protein
induc
h
addit
mm
isopropyl
iptg
harvest
centrifug
e
coli
pellet
wash
phosphat
buffer
salin
solut
pb
resuspend
mm
pb
ph
mm
nacl
frozen
freez
thaw
three
time
cell
suspens
sonic
min
interv
puls
centrifug
g
min
supernat
appli
imac
resin
column
clontech
usa
wash
bind
buffer
mm
pb
mm
nacl
contain
mm
imidazol
ph
purifi
protein
elut
elut
buffer
mm
pb
mm
nacl
contain
mm
imidazol
ph
protein
solut
aliquot
store
final
concentr
glycerol
use
protein
concentr
determin
bradford
method
use
biorad
protein
assay
reagent
kit
biorad
usa
puriti
protein
analyz
sodium
dodecyl
sulfatepolyacrylamid
gel
electrophoresi
sdspage
western
blot
analysi
perform
describ
briefli
protein
marker
precis
plu
protein
standard
biorad
sftsv
infect
cell
lysat
purifi
recombin
protein
separ
gradient
polyacrylamid
gel
atto
corpor
japan
electrotransf
onto
pvdf
membran
immobilon
millipor
usa
use
semidri
electroblott
sartoriu
germani
membran
block
blockac
yokijirushi
sapporo
japan
overnight
prevent
nonspecif
stain
subject
reaction
mous
antihistidin
ge
healthcar
life
dilut
patient
serum
sampl
dilut
h
incub
rabbit
antimous
igg
goat
antihuman
peroxidas
conjug
american
qualex
califonia
dilut
h
final
reaction
visual
dimethyl
aminobenzidin
dab
stain
serum
sampl
two
sftsconfirm
patient
healthi
volunt
dilut
dilut
dilut
sera
check
rsftsvn
base
indirect
igg
igm
elisa
separ
describ
appropri
dilut
serum
sampl
two
assay
determin
base
od
valu
nm
evalu
use
diagnosi
rsftsvn
protein
develop
establish
indirect
igg
igm
elisa
laboratori
diagnosi
sftsv
infect
human
serum
sampl
clinic
specimen
assay
common
procedur
describ
procedur
specif
assay
describ
assay
plate
use
nunc
immunopl
thermo
scientif
denmark
reagent
volum
optim
concentr
rsftsvn
protein
use
coat
micropl
determin
checkerboard
titrat
refer
serum
sampl
sftsconfirm
patient
healthi
volunt
coat
buffer
pb
ph
plate
coat
conduct
overnight
wash
buffer
pb
volvol
tween
pbst
plate
wash
three
time
pbst
exposur
specif
reagent
step
procedur
except
last
step
describ
dilut
serum
sampl
reagent
nonfat
milk
difco
detroit
usa
pbst
incub
except
substrat
done
h
plate
h
abt
substrat
kirkegaatrd
perri
gaithersburg
md
well
incub
min
plate
read
spectrophotometr
od
valu
nm
record
indirect
igg
elisa
plate
subject
follow
step
coat
well
ng
rsftsvn
protein
per
well
follow
human
serum
sampl
dilut
nonfat
milk
pbst
detect
bound
igg
dilut
horseradishperoxidaseconjug
goat
antihuman
igg
american
qualex
califonia
usa
made
visibl
ad
h
abt
substrat
last
reagent
seri
procedur
od
valu
nm
record
micropl
spectrophotomet
serum
sampl
test
duplic
mean
od
sampl
calcul
refer
serum
sampl
run
everi
assay
mean
od
sampl
twice
mean
od
neg
control
serum
consid
posit
procedur
indirect
igm
elisa
similar
igg
elisa
chang
serum
sampl
dilut
detect
bound
igm
donewith
dilut
horseradish
peroxidaseconjug
goat
antihuman
igm
american
qualex
califonia
usa
serum
sampl
suspect
sft
patient
subject
commerci
elisa
kit
xinlianxin
biomed
technolog
co
ltd
wuxi
jiangsu
china
follow
manufactur
protocol
kit
doubleantigen
sandwich
enzymelink
immunosorb
assay
kit
detect
total
antibodi
includ
igg
igm
sftsv
result
obtain
use
total
antibodi
elisa
kit
compar
result
obtain
appli
igg
igm
indirect
elisa
describ
research
approv
institut
review
board
center
diseas
control
prevent
henan
provinc
particip
gave
written
inform
consent
use
serum
sampl
research
purpos
